KVUE logo

KVUE

Kenvue Inc.

$16.64
+$0.49(+3.03%)
63
Overall
100
Value
27
Tech
--
Quality
Market Cap
$30.34B
Volume
46.90M
52W Range
$14.02 - $25.17
Target Price
$19.17

Company Overview

Mkt Cap$30.34BPrice$16.64
Volume46.90MChange+3.03%
P/E Ratio29.5Open$16.25
Revenue$15.5BPrev Close$16.15
Net Income$1.0B52W Range$14.02 - $25.17
Div Yield0.83%Target$19.17
Overall63Value100
Quality--Technical27

No chart data available

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Sector: Personal & Household Products & Services
Industry: All Other Health and Personal Care Stores

Latest News

Kenvue, Inc. (KVUE) Gets a Hold from Barclays

In a report released on November 7, Lauren Lieberman from Barclays maintained a Hold rating on Kenvue, Inc., with a price target of $18.00. The com...

TipRanks Auto-Generated Intelligence Newsdesk14 days ago

RBC Capital Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE)

TipRanks Auto-Generated Intelligence Newsdesk18 days ago

M&A: Diaper Maker Kimberly-Clark Leaks 15% After $48.7B Purchase of Tylenol Maker Kenvue

David Craik20 days ago

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

William Whitea month ago

Texas AG’s Tylenol Lawsuit Rattles Kenvue Stock (KVUE)

William Whitea month ago
ABCD
1SymbolPriceChangeVol
2KVUE$16.64+3.0%46.90M
3
4
5
6

Get Kenvue Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.